Study links uterine fibroids to elevated cardiovascular risk in women

Researchers analyzing health records from 2.7 million American women have uncovered a connection between uterine fibroids and heart disease that has largely escaped medical attention. The study, published in the Journal of the American Heart Association and led by scientists at the University of Pennsylvania, compared 450,177 women diagnosed with fibroids to 2.25 million without the condition, tracking cardiovascular events over time. The findings are stark: women with fibroids face an 81% higher risk of developing cardiovascular disease within the next decade. For women under 40, the elevation is even more severe—a 3.5-fold increase in risk, a particularly striking figure given that this age group is typically considered low-risk for heart disease by conventional medical standards.

Uterine fibroids are benign growths that develop in the uterus, ranging in size from microscopic to as large as a cantaloupe, and occurring either singly or in clusters. They affect up to 80% of women by age 50, yet have long been treated by clinicians as a manageable nuisance, with medical attention focused primarily on managing symptoms like heavy bleeding or pelvic pain. The new research challenges that dismissive framing. Within just one year of a fibroid diagnosis, affected women showed 2.47 times the cardiovascular risk of their peers without fibroids. The gap widened substantially over time. A decade after diagnosis, 5.42% of women with fibroids had experienced a heart attack, stroke, or similar cardiovascular emergency, compared to 3% of women without fibroids. Every category of cardiovascular disease tracked in the study showed elevation, suggesting a systemic problem rather than coincidence.

The biological mechanisms linking these two conditions appear to be rooted in shared pathways involving inflammation, abnormal cell proliferation, and metabolic dysfunction. Fibroids generate chronic inflammation throughout the body by acting as factories for inflammatory proteins that flood the bloodstream. This state of persistent, body-wide inflammation is a known driver of atherosclerosis—the plaque buildup in arteries that leads to heart attacks and strokes. Additionally, women with fibroids often exhibit a metabolic profile that independently threatens cardiovascular health: insulin resistance, unfavorable cholesterol levels, obesity, and high blood pressure. The fibroid itself may be a visible marker of this underlying metabolic dysfunction, which simultaneously damages the vascular system.

The most alarming findings center on younger women. Those diagnosed with fibroids before age 40 showed the most dramatic risk elevation, suggesting that the biological processes linking these conditions begin causing damage early in life. This population, typically considered low-risk by traditional cardiology metrics, may be carrying a significant and unaddressed threat to their long-term health. The research exposes what some describe as a critical flaw in modern healthcare: its extreme compartmentalization. A gynecologist manages the uterus, a primary care physician monitors cholesterol, and a cardiologist waits for traditional risk factors to appear. No single practitioner is systematically trained to connect these dots. The body is treated as a collection of separate systems, leaving patients—particularly women—vulnerable to overlooking clear warning signs.

This fragmentation has deep historical roots. Women's health, particularly concerning reproductive organs, has long been separated from what is considered "serious" medicine like cardiology. Symptoms are often minimized, and conditions like fibroids are normalized to the point where their potential systemic implications are never explored. The new study serves as a direct challenge to that separation. For the millions of women with fibroids, the research suggests that cardiovascular protection should begin at the moment of diagnosis. This would involve comprehensive cardiovascular risk assessment, including advanced lab tests capable of detecting arterial inflammation and damage early. It would require healthcare providers to view a woman's body as an interconnected whole rather than a collection of isolated organ systems. The study concludes that uterine fibroids are associated with sustained increases in cardiovascular risk for at least a decade after diagnosis—not merely a statistical association, but an early warning system embedded in women's bodies that medicine has, until now, largely failed to recognize.